3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Carboplatin
40
Cisplatin
37
Pemetrexed
33
Radiotherapy
23
Paclitaxel
22
pembrolizumab
20
durvalumab
19
Docetaxel
19
Gemcitabine
18
Nivolumab
15
Radiosurgery
14
Etoposide
13
atezolizumab
11
Erlotinib Hydrochloride
11
Taxes
8
Magnetic Resonance Spectroscopy
8
Drug Therapy
8
Bevacizumab
8
Cyclophosphamide
7
Platinum
6
Gefitinib
6
Surveys and Questionnaires
5
Biopsy
5
130-nm albumin-bound paclitaxel
5
1,2-diaminocyclohexaneplatinum II citrate
5
sotorasib
4
Ramucirumab
4
Radiation
4
Immunotherapy
4
Fluorodeoxyglucose F18
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Patient-Specific Modeling
×
Thoracic
×
Clear all
NCT02000739
2014-07-14
GENIUS
Dartmouth-Hitchcock Medical Center
Phase 4
Withdrawn